FDA
-
-
-
-
-
-
-
RedHill sells Talicia to Apotex for $18M upfront plus milestones
-
-
-
-
-
-
-
RedHill initiates enforcement of $10.9 million judgment in Korea
-
-
-
-
-
-
-
RedHill's Opaganib Enhances Efficacy of Neuroblastoma Chemo Combination and Augment Anti-Tumor Immunity in Triple-Negative Breast Cancer in Preclinical Studies - New Data Presented at AACR 2026
-
-
-
-
-
-
-
RedHill Biopharma regains NASDAQ stockholders' equity compliance
-
-
-
-
-
-
-
RedHill Biopharma Receives Nasdaq Staff Determination Notification
-
-
-
-
-
-
-
RedHill Biopharma wins $10 million court judgment on appeal
-
-
-
-
-
-
-
RedHill gets FDA guidance for Crohn's disease drug trial design
-
334,853 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


